Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/jama.2015.4978 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Factors associated with smoking cessation in patients with peripheral arterial disease consulting French cessation services.
J Vasc Surg
March 2025
Outpatient Addictology Center, Department of Psychiatry and Addictology, Hôpital Européen Georges Pompidou, AP-HP Centre-Université Paris Cité, Paris, France; Groupement d'Intérêt Scientifique du Réseau Français d'Excellence de Recherche sur Tabac, nicotine et produit connexes (GIS REfer Tab); Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France. Electronic address:
Objective: Smoking is a strong independent risk factor for peripheral arterial disease (PAD) incidence and quitting is a key factor of the disease evolution. This study aimed to describe the characteristics of smokers with PAD included in the French smoking cessation services (SCS) database CDTnet, as well as to identify factors associated with their abstinence. We hypothesized that certain PAD smokers' characteristics would influence quit rates.
View Article and Find Full Text PDFBlood pressure changes during smoking cessation in a randomized, double-blind, placebo-controlled trial of dulaglutide treatment.
Eur J Prev Cardiol
March 2025
Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
Aims: Cigarette smoking cessation reduces cardiovascular risk via various mechanisms. Thereby, the role of blood pressure remains unclear, with studies reporting both decreased and increase blood pressure values after cessation, potentially influenced by weight change. We previously showed that the glucagon like peptide-1 analogue dulaglutide mitigates weight gain after smoking cessation.
View Article and Find Full Text PDFPrior Authorization, Quantity Limits, and Costs for Varenicline in Medicare.
JAMA Netw Open
March 2025
Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas.
EBM BLS: E-Cigarettes and Varenicline are Both Effective for Smoking Cessation.
J Gen Intern Med
February 2025
University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.
Smoking Cessation Strategies After Acute Coronary Syndrome.
J Clin Med
February 2025
Cardiothoracic Directorate, Heart and Lung Center, New Cross Hospital, Royal Wolverhampton Trust, Wolverhampton WV10 0QP, UK.
Smoking is one of the strongest modifiable risk factors for coronary artery disease. It is the cause of approximately 10-30% of deaths due to cardiovascular disease around the world. There is a 50% reduction in the risk of myocardial infarction by one year for people who successfully quit smoking.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!